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highest (85.5%) specificity, followed by lavage cytology 
(85.2%), ductoscopy (49.4%), galactography (44.4%), 
mammography (33.3%), sonography (17.9%), and MRI 
(11.8%). Conclusion: Currently, ductoscopy provides a 
direct intraoperative visualization of intraductal lesions. 
Sensitivity and specificity are similar to those of stan-
dard diagnostics. The technique supports selective duct 
excision, in contrast to the unselective technique accord-
ing to Urban. Therefore, ductoscopy extends the inter-
ventional/diagnostic armamentarium.
Introduction
Female breast disorders are frequently associated with nip-
ple discharge (ND) [1]. Pathologic ND needs to be distin-
guished from physiologic discharge, such as discharge during 
pregnancy and breast-feeding. Medications can also cause ND 
[1, 2]. Spontaneous unilateral discharge from one or several 
ducts signifies pathological discharge [2, 3]. Both benign and 
malignant breast disorders can be associated with ND. Among 
benign lesions associated with ND, papilloma is especially im-
portant: Approximately 50% of patients with a papilloma 
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Summary
Background: According to the literature, ductoscopy is 
gaining increasing importance in the diagnosis of intra-
ductal anomalies in cases of pathologic nipple discharge. 
In a multicenter study, the impact of this method was as-
sessed in comparison with that of standard diagnostics. 
Patients and Methods: Between 09/2006 and 05/2009, 
a total of 214 patients from 7 German breast centers 
were included. All patients underwent elective ducto-
scopy and subsequent ductal excision because of patho-
logic nipple discharge. Ductoscopy was compared with 
the following standard diagnostics: breast sonography, 
mammography, magnetic resonance imaging (MRI), ga-
lactography, cytologic nipple swab, and ductal lavage 
cytology. The histological and imaging results were 
compared and contrasted to the results obtained from 
the nipple swab and cytologic assessment. Results: 
Sonography had the highest (82.9%) sensitivity, followed 
by MRI (82.5%), galactography (81.3%), ductoscopy 
(71.2%), lavage cytology (57.8%), mammography 
(57.1%), and nipple swab (22.8%). Nipple swabs had the 




The study included 261 women. 47 women were excluded: In 
23 cases, ductoscopy was not followed by duct excision, a false 
passage was created in 7 cases, no mammary duct could be 
identified in 1 case, and in 2 cases, the ductoscope could not be 
advanced far enough and the procedure was prematurely 
aborted. These cases were counted as ‘not completed’. 
Intraoperatively, no discharge could be elicited in 1 woman. 10 
women underwent duct excision without prior ductoscopy. 
Data entry had been duplicated in 3 women. The mammary 
duct was successfully visualized in a total of 214 patients. All 
patients included in this study received a ductoscopy. Among 
these, no postoperative complications occurred, such as wound 
infections, duct perforation, pain or postoperative hemorrhage.
The average patient age was 52.2 years (age range: 19–86 
years). The mean number of visualized ducts was 2.3 (range: 
1–12 ducts) and the average depth was 42.3 mm (range: 
1–90 mm).
Table 1 demonstrates the general results.
Due to different reasons (e.g. refusal of the diagnostic 
method by the patient, contraindication, lack of funds, missing 
data), it was not possible to give each woman all diagnostics as 
planned in the study design. Therefore, each diagnostic 
method shows variable case numbers.
Sonography was performed in 212, mammography in 191, 
MRI in 88, galactography in 120, nipple swabs in 134, and 
ductal lavage in 72 patients. These respective results were cor-
related with the ductoscopic findings.
The histology was benign in 89 cases (41.6%) (cell detritus, 
galactophoritis, fibroadenomas), mammary duct papillomas 
were found in 110 cases (51.4%), atypical ductal hyperplasia 
(ADH) in 4 cases (1.9%), DCIS was observed in 10 cases 
have ND, and 5–17% of papillomas will eventually turn malig-
nant [4–6]. ND is also observed in 0.5–12% of malignant 
breast lesions, especially in ductal carcinoma in situ (DCIS) 
and invasive ductal carcinoma (IDC) [1, 2]. It is thought that 
85% of malignant and premalignant breast disorders originate 
in the ductal epithelium [7–10]. Conventional imaging and cy-
tologic diagnostics provide only indirect information on the 
ducts. Which duct is affected cannot be specified [11]. 
Ductoscopy can directly depict intraductal lesions and shows 
other pathologies indirectly, i.e. in cases of ductal obstruction. 
To a certain extent, the endoscopic findings provide informa-
tion about the probable histologic diagnosis [12, 13].
Recent technical advances have provided endoscopes with 
a working channel permitting tissue biopsies [14–17]. Thereby, 
ductoscopy plays an important role in the efforts to minimize 
unnecessary open biopsies [18].
This multicenter trial aimed to assess to what extent duc-
toscopy is capable of detecting intraductal anomalies in condi-
tions associated with ND, in comparison with conventional 
diagnostic methods. We compared the sensitivities, specifici-
ties, and efficiencies of the diverse methods.
Patients and Methods
From September 2006 to May 2009, a total of 214 patients with patho-
logic ND underwent ductoscopy and subsequent ductal excision under 
general anesthesia. 7 German centers participated in this multicenter 
study, which was not randomized. Patients with spontaneous or elicited 
uni- or bilateral ND were included. All patients gave their consent to par-
ticipate in the study. Any extramammary etiology of ND was a criterion 
for exclusion. The ethics commission of the Ernst-Moritz-Arndt 
University Greifswald approved the study.
Preoperative diagnostics included breast sonography, mammography, 
breast magnetic resonance imaging (MRI), galactography, nipple swab, 
and ductal lavage cytology. All patients received a ductal excision after 
ductoscopy was completed, to compare the results of preoperative diag-
nostics and ductoscopy with the histological findings.Figure 1 gives an 
overview of the study design.
The mammographic results were classified in accordance with the 
Breast Imaging Reporting and Data System (BI-RADS) [19]. All ultra-
sonographic findings were reported in accordance with the BI-RADS-
analogous criteria of the DEGUM (Deutsche Gesellschaft für Ultraschall 
in der Medizin, German Society for Ultrasound in Medicine [20].
Ductoscopy was performed with endoscopes equipped with 0.9-mm 
optics (Karl Storz GmbH and Co. KG, Tuttlingen, Germany) under gen-
eral anesthesia. ND was elicited by application of steady areolar pressure 
and the affected duct was then dilated with Hegar dilators. The mammary 
ducts were visualized under hydrodilatation with saline solution injected 
through the working channel of the ductoscope. The ductoscope was ei-
ther left in place at completion of ductoscopy or a marking wire was 
placed for the subsequent open excision of the affected duct. The speci-
men was marked with sutures to permit spatial orientation for the histo-
logic analysis. The histopathologic result served as a reference in calculat-
ing the sensitivity, specificity, and efficiency figures associated with the 
various diagnostics, regardless of the benign or malignant character of the 
ductal epithelium. Data were analyzed with the IBM SPSS Statistics soft-
ware version 19.0.
Fig. 1. Overview of the study design.




This multicenter center study compared the sensitivity, 
specificity; and efficiency of ductoscopy in cases of pathologic 
ND to the respective results of standard diagnostics.
The suitability of mammography for diagnosing the cause 
of ND is limited. Detecting intraductal processes in mammo-
grams is difficult (sensitivity 57.1%, specificity 33.3%). The 
figures in the literature range from 7 to 10% for sensitivity 
and from 94 to 100% for specificity [21, 22]. In their study on 
71 patients, Grunwald et al. [10] reported a sensitivity of 
37.9% and a specificity of 92.3%. In their retrospective study, 
Albrecht et al. [23] calculated a sensitivity of 9% and a speci-
ficity of 100%, explaining the low sensitivity with a large num-
ber of false-negative results.
Breast high-resolution ultrasound is optimally suited for 
imaging intraductal lesions, with a sensitivity of 82.9% and a 
specificity of 17.9% in this study. Other researches show sensi-
tivities between 26 and 67.3% and specificities of 61.5 and 
97% [10, 21–23]. Due to fluid surrounding intraductal pro-
cesses, ultrasonography of the ducts is very sensitive in uncov-
ering such lesions. If pathological discharge correlates with a 
sonographically detected lesion, such lesions can be reliably 
diagnosed by vacuum biopsy [24].
Only a small number of studies have addressed MRI as a 
diagnostic in cases of pathologic ND, with a sensitivity of 
82.5% and a specificity of 11.8%. The literature reports sensi-
tivities ranging from 60 to 77% corresponding with specifici-
ties between 25 and 66.7% [10, 23, 25]. Differences between 
our results and those reported in previous studies can be ex-
plained by variations in image interpretation. Nakahara et al. 
[26] compared breast sonography, galactography and 3-dimen-
sional MRI, finding the latter the most suitable method for 
localizing and for sizing lesions. Hirose et al. [27] also com-
pared contrast MRI with 2-dimensional galactography. Again, 
contrast MRI was superior.
Galactography is currently considered the ‘state of the art’ 
for diagnosing intraductal lesions [2]. The technique has the 
shortcoming that it cannot clarify if any observed duct nar-
rowing is in- or extrinsic [2, 11]. It achieved a sensitivity of 
81.3% and a specificity of 44.4% in our study. The respective 
figures in the literature vary: Reported sensitivities are in the 
(4.7%) and invasive cancer in 1 case (0.5%). The following 
histologic results were considered conspicuous: papilloma, 
ADH, DCIS, invasive carcinoma. Cell detritus, galactophoritis, 
and fibroma were treated as unremarkable findings.
Breast sonography was performed in 212 patients (99.1%). 
Ultrasonographic findings according to BI-RADS classifica-
tion were recorded in 175 cases. There were 123 conspicuous 
and 89 unremarkable final histologic findings. The calculated 
sensitivity was 82.9% and the specificity 17.9%.
Mammography was completed in 191 patients (89.3%). 
Mammographic correlates evaluated according to BI-RADS 
classification were found in 116 cases. Unremarkable histo-
logic findings were recorded in 72 and conspicuous findings in 
119 cases. Mammography had a sensitivity of 57.1% and a 
specificity of 33.3%.
MRI was performed in 88 women (41.1%), revealing 77 
suspicious findings. There were 34 unremarkable and 54 con-
spicuous histologic results. MRI had a calculated sensitivity of 
82.5% and a specificity of 11.8%.
Galactography was completed in 120 cases (56.1%). The 
ductal system was unremarkable in 34 cases. Possible intra-
ductal lesions were reported in 86 cases. Final histologic analy-
sis revealed 45 unremarkable and 75 suspicious findings. Galac-
tography had a sensitivity of 81.3% and a specificity of 44.4%.
Nipple swabs were performed in 134 patients (62.6%). 
Unremarkable mammary ductal epithelium was seen in 108 of 
these; evidence for a papilloma or carcinoma was found in 26 
cases. Final histology revealed 55 unremarkable findings and 
79 conspicuous lesions. The sensitivity was 22.8% and the 
specificity 85.5%.
Ductal lavage cytology was completed in 72 patients 
(33.6%). In 42 cases, mammary duct epithelial cells were de-
scribed as unremarkable, and suspicious findings were re-
ported in 30 cases. Final histologic workup revealed unre-
markable findings in 27 and suspicious findings in 45 cases. 
Ductal lavage cytology had a calculated sensitivity of 57.8% 
and a specificity of 85.2%.
Ductoscopy revealed lesions in 134 of 214 cases (62.6%) and 
no lesions in 80 cases (37.4%). The final histology analyses of 
the ductal excision were unremarkable in 89 and suspicious in 
125 cases. Ductoscopy had a sensitivity of 71.2% and a specific-
ity of 49.4%. Table 2 summarizes the results of all techniques.
Sensitivity, % Specificity, % PPV, % NPV, % Efficiency, %
Galactography 81.3 44.4 70.9 58.8 67.5
Ductal lavage cytology 57.8 85.2 86.7 54.8 68.1
Ductoscopy 71.2 49.4 66.4 55.0 62.1
Breast MRI 82.5 11.8 61.0 36.4 57.9
Breast ultrasonography 82.9 17.9 58.3 43.2 55.7
Nipple swab 22.8 85.5 69.2 43.5 48.5
Mammography 57.1 33.3 58.6 32.0 48.2
PPV = Positive predictive value, NPV = negative predictive value.
Table 2. Summary 
of the performance of 
the various diagnos-
tics for detecting in-
traductal anomalies
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no duct was any longer identifiable. No further complications 
were reported.
In addition to evaluating the particular diagnostic methods 
individually, we attempted to maximize the diagnostic yield by 
combining methods. Because of the variable case number for 
each technique, combinations of three and more methods did 
not include a sufficient number of patients to calculate mean-
ingful sensitivities and specificities. Feasibility and cost effec-
tiveness are additional issues. Clear conclusions on the signifi-
cance of combinations would require matching numbers of 
tests. A follow-up for this study is planned and will be part of a 
different publication.
Conclusion
Ductoscopy provides direct intraoperative visualization of 
intraductal anomalies in patients with pathologic ND. The en-
doscope’s working channel and wire marking provide options 
for selective excision of intraductal lesions. Ductoscopy is an 
easily performed technique with a high sensitivity and a low 
rate of complications.
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range of 50–94%, specificities in the range of 41–66.7% [10, 
22, 23, 28, 29].
Cytologic ductal lavage performed during ductoscopy had 
a sensitivity of 57.8% and a specificity of 85.2% in this study. 
Yamamoto et al. [30] reported a specificity of 94.3%, a sensi-
tivity of 50%, and an efficiency of 89.7%. Matsunaga et al. [31] 
compared nipple swab, biopsy, and cytologic ductal lavage. In 
their study, cytologic lavage had a sensitivity of 82.8%.
In our study, nipple swab achieved a low sensitivity 
(22.8%). Grunwald et al. [10] reported a sensitivity of 36.7% 
while Dinkel et al. [29] revealed a sensitivity of 31.2%. Some 
authors continue to recommend nipple swabs despite their 
poor sensitivity.
Ductoscopy is an innovative method for visualizing intra-
ductal breast lesions. It is especially advantageous for detect-
ing partially obstructive lesions. The method can also identify 
multiple lesions affecting a duct. This diagnostic technique had 
a sensitivity of 71.2% and a specificity of 49.4% in our multi-
center study. These data are significant and consistent with sev-
eral preliminary studies. In their retrospective study, Grunwald 
et al. [10] computed a sensitivity of 55.2% and a specificity of 
61.5%. Albrecht et al. [23] reported a sensitivity of 53.2% and 
a specificity of 60%. Yamamoto et al. [30] compared ductos-
copy and galactography in 65 patients. In these authors’ study, 
intraductal anomalies were detected by galactography in 
89.1%, by ductoscopy in 97.4%, and in 97.5% of the cases with 
both methods combined. Dietz et al. [32] published a study on 
119 patients with pathologic ND, reporting that galactography 
detected 76% and ductoscopy 90% of the underlying anoma-
lies. Schultz-Wendtland et al. [33] evaluated 22 patients with 
hemorrhagic ND, finding 20 benign and 2 malignant lesions. 
With 95.5%, ductoscopy achieved the highest accuracy while 
galactography and nipple swabs detected only benign lesions. 
Only 12 lesions were found by breast sonography; no diagnos-
tic information was obtained in the remaining 10 cases.
Ductoscopy has a low complication rate [2, 34, 35]. In this 
study, a false passage was created in 7 cases, and in just 1 case, 
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